SaaS

Digital

How biotech can leverage scientific enterprise SaaS

By considering how to build a solid data foundation from the beginnings, smaller start-ups or biotechs can make sure they are ready to go.

Market Access

Biotech ≠ tech: Why venture capital needs a new playbook for...

Silicon Valley investors have been conditioned by two decades of software: launch quickly, capture users faster, and hit the magic $1 million ARR mark within about three years,1

Digital

Pharma dips toe into tech adoption, but is it deep enough?

Ben Hargreaves looks at the uptake of enabling technology by the pharma industry.

How biotech can leverage scientific enterprise SaaS

Biotech ≠ tech: Why venture capital needs a new playbook for...

Pharma dips toe into tech adoption, but is it deep enough?

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks